Meeder Advisory Services, Inc. Moderna, Inc. Transaction History

Meeder Advisory Services, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$101.21 - $166.61 $153,434 - $252,580	1,516 Added 78.51%	3,447 $409 Million
Q1 2024 May 07, 2024	BUY	$85.37 - $115.44 $164,849 - $222,914	1,931 New	1,931 $206 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $132,274 - $173,708	-1,372 Reduced 40.72%	1,997 $206 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $97,762 - $132,437	-825 Reduced 19.67%	3,369 $409 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $22,519 - $32,705	166 Added 4.12%	4,194 $644 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $476,834 - $846,041	4,028 New	4,028 $724 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Meeder Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Meeder Advisory Services, Inc. with notifications on news.